Relevance of Baseline Viral Genetic Heterogeneity and Host Factors for Treatment Outcome Prediction in Hepatitis C Virus 1b-Infected Patients

BACKGROUND: Only about 50% of patients chronically infected with HCV genotype 1 (HCV-1) respond to treatment with pegylated interferon-alfa and ribavirin (dual therapy), and protease inhibitors have to be administered together with these drugs increasing costs and side-effects. We aimed to develop a...

Descripción completa

Detalles Bibliográficos
Autores principales: Saludes, Verónica, Bascuñana, Elisabet, Jordana-Lluch, Elena, Casanovas, Sònia, Ardèvol, Mercè, Soler, Esther, Planas, Ramón, Ausina, Vicente, Martró, Elisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755994/
https://www.ncbi.nlm.nih.gov/pubmed/24015264
http://dx.doi.org/10.1371/journal.pone.0072600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755994/
https://www.ncbi.nlm.nih.gov/pubmed/24015264
http://dx.doi.org/10.1371/journal.pone.0072600

Ejemplares similares